Related references
Note: Only part of the references are listed.The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration
David Heras-Sandoval et al.
CELLULAR SIGNALLING (2014)
mTOR inhibitors: changing landscape of endocrine-resistant breast cancer
Saranya Chumsri et al.
FUTURE ONCOLOGY (2014)
Verapamil-induced autophagy-like process in colon adenocarcinoma COLO 205 cells; the ultrastructural studies
Beata Pająk et al.
Pharmacological Reports (2014)
rnTOR signaling and its roles in normal and abnormal brain development
Nobuyuki Takei et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2014)
A novel crosstalk between two major protein degradation systems Regulation of proteasomal activity by autophagy
Xiao J. Wang et al.
AUTOPHAGY (2013)
Autophagy and genomic integrity
A. T. Vessoni et al.
CELL DEATH AND DIFFERENTIATION (2013)
Mouse gene targeting reveals an essential role of mTOR in hematopoietic stem cell engraftment and hematopoiesis
Fukun Guo et al.
HAEMATOLOGICA (2013)
Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers
Naif AlQurashi et al.
HUMAN PATHOLOGY (2013)
Dual Inhibition of PI3K and mTOR Mitigates Compensatory AKT Activation and Improves Tamoxifen Response in Breast Cancer
Xiaosong Chen et al.
MOLECULAR CANCER RESEARCH (2013)
Unfolded protein response to autophagy as a promising druggable target for anticancer therapy
Dong Hoon Suh et al.
NUTRITION AND PHYSICAL ACTIVITY IN AGING, OBESITY, AND CANCER (2012)
Guidelines for the use and interpretation of assays for monitoring autophagy
Daniel J. Klionsky et al.
AUTOPHAGY (2012)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
mTOR Signaling Pathway and mTOR Inhibitors in Cancer Therapy
Alejandro Gomez-Pinillos et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2012)
Verapamil stereoisomers induce antiproliferative effects in vascular smooth muscle cells via autophagy
Joshua K. Salabei et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
Overcoming breast cancer drug resistance with mTOR inhibitors. Could it be a myth or a real possibility in the short-term future?
Nadia Margariti et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1
Isaam Ben Sahra et al.
CANCER RESEARCH (2011)
mTOR signaling in disease
Eva Dazert et al.
CURRENT OPINION IN CELL BIOLOGY (2011)
PI3K/AKT/mTOR pathway in angiogenesis
Jayashree Karar et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2011)
Mammalian Target of Rapamycin (mTOR) Regulates Cellular Proliferation and Tumor Growth in Urothelial Carcinoma
Donna E. Hansel et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Dissecting the role of mTOR: Lessons from mTOR inhibitors
Ryan J. O. Dowling et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
Methods in Mammalian Autophagy Research
Noboru Mizushima et al.
CELL (2010)
Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-Dependent Manner
Adem Kalender et al.
CELL METABOLISM (2010)
Deciphering the Role of PI3K/Akt/mTOR Pathway in Breast Cancer Biology and Pathogenesis
Priscilla F. McAuliffe et al.
CLINICAL BREAST CANCER (2010)
Dysregulation of the mTOR Pathway Mediates Impairment of Synaptic Plasticity in a Mouse Model of Alzheimer's Disease
Tao Ma et al.
PLOS ONE (2010)
mTOR signaling at a glance
Mathieu Laplante et al.
JOURNAL OF CELL SCIENCE (2009)
The role of protein synthesis in cell cycling and cancer
Shai White-Gilbertson et al.
MOLECULAR ONCOLOGY (2009)
AMPK in Health and Disease
Gregory R. Steinberg et al.
PHYSIOLOGICAL REVIEWS (2009)
Rheb controls misfolded protein metabolism by inhibiting aggresome formation and autophagy
Xiaoming Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Role of the aggresorne pathway in cancer: Targeting histone deacetylase 6-dependent protein degradation
Agustin Rodriguez-Gonzalez et al.
CANCER RESEARCH (2008)
Activation of the mTOR signaling pathway in breast cancer and its correlation with the clinicopathologic variables
Woo Chul Noh et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability
Wen-Xing Ding et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
LC3, an autophagosome marker, can be incorporated into protein aggregates independent of autophagy
Akiko Kuma et al.
AUTOPHAGY (2007)
AMPK-mediated inhibition of mTOR kinase is circumvented during immediate-early times of human cytomegalovirus infection
Sagar B. Kudchodkar et al.
JOURNAL OF VIROLOGY (2007)
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Mahvash Zakikhani et al.
CANCER RESEARCH (2006)
Predicted mechanisms of resistance to mTOR inhibitors
R. T. Kurmasheva et al.
BRITISH JOURNAL OF CANCER (2006)
mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells
M Murakami et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
The target of rapamycin (TOR) proteins
B Raught et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Regulation of translation initiation by FRAP/mTOR
AC Gingras et al.
GENES & DEVELOPMENT (2001)
TOR, a central controller of cell growth
T Schmelzle et al.
CELL (2000)
Share Paper
